Vicore Pharma is leveraging its understanding of the Renin-Angiotensin System (RAS) to develop angiotensin II type 2 receptor agonists for IPF and beyond
- blonca9
- 4 days ago
- 1 min read
CEO Ahmed Mousa walks us through the sciences and describes how data stacked up against a synthetic external control that was presented at a medical meeting this summer.
Coverage brought to you by












.png)




